• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊拉克儿童疫苗接种成本:一项横断面研究。

Costs of childhood vaccine delivery in Iraq: a cross-sectional study.

机构信息

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Program Group, UNICEF, New York City, New York, USA.

出版信息

BMJ Open. 2022 Sep 13;12(9):e059566. doi: 10.1136/bmjopen-2021-059566.

DOI:10.1136/bmjopen-2021-059566
PMID:36100299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9472113/
Abstract

OBJECTIVES

In recent years, Iraq has expanded and revised the childhood immunisation schedule, but estimates of the costs of the programme are unavailable. The objective of this study was to estimate the economic costs of delivering childhood vaccines in Iraq from a government perspective.

SETTING

Health facilities were sampled using multistage probabilistic sampling and stratifying the country into three regions: Central and South, North/Kurdistan Region, and Retaken Areas. Cost data were collected from 97 health facilities and 44 district and regional vaccine stores. Total national costs were extrapolated using sample weight calibration.

PARTICIPANTS

Administrators at each health facility and vaccine store were interviewed using a standardised survey.

PRIMARY AND SECONDARY OUTCOME MEASURES

Total costs of vaccine delivery per year, costs per dose delivered and delivery costs per fully vaccinated child.

RESULTS

An estimated 15.3 million vaccine doses were delivered in 2018, costing US$99.35 million, excluding costs of vaccines and injection material. Nearly 90% of delivery costs were attributed to personnel salaries. Vaccine record-keeping and management (21%) and facility-based vaccine delivery (19%) were the largest cost contributors. Vaccine transport and storage, programme management, and outreach services represented 13%, 12% and 10%, respectively. All other activities represented less than 10% of the total cost. Average costs per dose delivered was US$6.48, ranging from US$9.13 in Retaken Areas to US$5.84 in the Central and South. Vaccine delivery costs per fully vaccinated child totalled US$149.

CONCLUSION

This study provides baseline evidence of the current programme costs and human resource uses which can be used for annual planning, identifying areas for improvement, and targeting strategies to increase programme efficiency.

摘要

目的

近年来,伊拉克扩大并修订了儿童免疫计划,但该计划的成本估算尚不可用。本研究旨在从政府角度估算伊拉克提供儿童疫苗的经济成本。

设置

使用多阶段概率抽样对卫生机构进行抽样,并将该国分为三个区域:中部和南部、北部/库尔德地区以及收复地区。从 97 个卫生机构和 44 个地区和区域疫苗储存库收集成本数据。使用样本权重校准推断全国总成本。

参与者

对每个卫生机构和疫苗储存库的管理人员使用标准化调查进行访谈。

主要和次要结果

每年疫苗接种总成本、每剂接种成本和完全接种儿童的接种成本。

结果

据估计,2018 年共接种了 1530 万剂疫苗,耗资 9935 万美元,不包括疫苗和注射材料成本。近 90%的接种成本归因于人员工资。疫苗记录保存和管理(21%)和基于设施的疫苗接种(19%)是最大的成本贡献者。疫苗运输和储存、方案管理和外展服务分别占 13%、12%和 10%。其他所有活动的成本均低于总成本的 10%。每剂疫苗接种的平均成本为 6.48 美元,从收复地区的 9.13 美元到中部和南部的 5.84 美元不等。每个完全接种儿童的疫苗接种总成本为 149 美元。

结论

本研究提供了当前方案成本和人力资源利用的基准证据,可用于年度规划、确定改进领域以及制定提高方案效率的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca9/9472113/176bbce0dd4c/bmjopen-2021-059566f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca9/9472113/176bbce0dd4c/bmjopen-2021-059566f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eca9/9472113/176bbce0dd4c/bmjopen-2021-059566f01.jpg

相似文献

1
Costs of childhood vaccine delivery in Iraq: a cross-sectional study.伊拉克儿童疫苗接种成本:一项横断面研究。
BMJ Open. 2022 Sep 13;12(9):e059566. doi: 10.1136/bmjopen-2021-059566.
2
Costs of the COVID-19 vaccination programme: estimates from the West Rand district of South Africa, 2021/2022.2021/2022 年南非西部兰德地区 COVID-19 疫苗接种计划成本估计。
BMC Health Serv Res. 2024 Jul 29;24(1):857. doi: 10.1186/s12913-024-11251-1.
3
How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.将一剂疫苗送到服务提供地点需要多少成本?来自越南扩大免疫规划的经验证据。
Vaccine. 2014 Feb 7;32(7):834-8. doi: 10.1016/j.vaccine.2013.12.029. Epub 2013 Dec 25.
4
Examining the cost of delivering routine immunization in Honduras.考察洪都拉斯提供常规免疫接种的成本。
Vaccine. 2015 May 7;33 Suppl 1:A53-9. doi: 10.1016/j.vaccine.2015.01.016.
5
Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania.免疫接种成本,从证据到政策:来自坦桑尼亚全国代表性成本研究和政策转化工作的发现。
Vaccine. 2020 Nov 10;38(48):7659-7667. doi: 10.1016/j.vaccine.2020.10.004. Epub 2020 Oct 17.
6
Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania.坦桑尼亚姆万扎地区为女学生提供人乳头瘤病毒疫苗接种的成本。
BMC Med. 2012 Nov 13;10:137. doi: 10.1186/1741-7015-10-137.
7
Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana.加纳常规免疫以及引入新的和未充分利用的疫苗的成本。
Vaccine. 2015 May 7;33 Suppl 1:A40-6. doi: 10.1016/j.vaccine.2014.12.081.
8
Using standardized tools to improve immunization costing data for program planning: the cost of the Colombian Expanded Program on Immunization.利用标准化工具改进免疫规划成本数据:哥伦比亚扩大免疫规划成本。
Vaccine. 2013 Jul 2;31 Suppl 3:C72-9. doi: 10.1016/j.vaccine.2013.05.038.
9
Variation in cost and performance of routine immunisation service delivery in India.印度常规免疫服务提供的成本与绩效差异。
BMJ Glob Health. 2018 Jun 22;3(3):e000794. doi: 10.1136/bmjgh-2018-000794. eCollection 2018.
10
Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania.估算肯尼亚和坦桑尼亚部分地区疫苗供应链及服务交付的成本。
Vaccine. 2015 May 28;33(23):2697-703. doi: 10.1016/j.vaccine.2015.03.084. Epub 2015 Apr 9.

引用本文的文献

1
Annual cost savings of US$70 million with similar outcomes: vaccine procurement experience from Iraq.每年节省7000万美元且效果相似:伊拉克的疫苗采购经验。
BMJ Glob Health. 2022 Feb;7(2). doi: 10.1136/bmjgh-2021-008005.

本文引用的文献

1
Annual cost savings of US$70 million with similar outcomes: vaccine procurement experience from Iraq.每年节省7000万美元且效果相似:伊拉克的疫苗采购经验。
BMJ Glob Health. 2022 Feb;7(2). doi: 10.1136/bmjgh-2021-008005.
2
Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011-30.免疫接种预防 94 个中低收入国家 10 种病原体的投资回报:2011-2030 年。
Health Aff (Millwood). 2020 Aug;39(8):1343-1353. doi: 10.1377/hlthaff.2020.00103.
3
Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates.
制定标准化国家免疫接种单位成本估算。
Pharmacoeconomics. 2020 Sep;38(9):995-1005. doi: 10.1007/s40273-020-00930-6.
4
The costs of delivering vaccines in low- and middle-income countries: Findings from a systematic review.低收入和中等收入国家的疫苗交付成本:系统评价结果
Vaccine X. 2019 Jul 15;2:100034. doi: 10.1016/j.jvacx.2019.100034. eCollection 2019 Aug 9.
5
Improved calibration estimators for the total cost of health programs and application to immunization in Brazil.改进卫生项目总成本的校准估计方法及其在巴西免疫接种中的应用。
PLoS One. 2019 Mar 6;14(3):e0212401. doi: 10.1371/journal.pone.0212401. eCollection 2019.
6
Quantifying and reducing statistical uncertainty in sample-based health program costing studies in low- and middle-income countries.量化并减少低收入和中等收入国家基于样本的卫生项目成本核算研究中的统计不确定性。
SAGE Open Med. 2018 Mar 22;6:2050312118765602. doi: 10.1177/2050312118765602. eCollection 2018.
7
The cost structure of routine infant immunization services: a systematic analysis of six countries.常规婴儿免疫服务的成本结构:六个国家的系统分析。
Health Policy Plan. 2017 Oct 1;32(8):1174-1184. doi: 10.1093/heapol/czx067.
8
The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.新推出疫苗的需求构成:埃塞俄比亚和马拉维引入肺炎球菌疫苗和轮状病毒疫苗的结果
Health Policy Plan. 2016 Jun;31(5):563-72. doi: 10.1093/heapol/czv103. Epub 2016 Feb 7.
9
Examining the cost of delivering routine immunization in Honduras.考察洪都拉斯提供常规免疫接种的成本。
Vaccine. 2015 May 7;33 Suppl 1:A53-9. doi: 10.1016/j.vaccine.2015.01.016.
10
Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC).常规免疫的成本与筹资:多国研究(EPIC)的方法与部分研究结果
Vaccine. 2015 May 7;33 Suppl 1:A13-20. doi: 10.1016/j.vaccine.2014.12.066.